Hua Z, Lin L, Yang W, Ma L, Huang M, Gao B
Mar Drugs. 2025; 23(2).
PMID: 39997209
PMC: 11857629.
DOI: 10.3390/md23020085.
de Cassia Collaco R, Van Petegem F, Bosmans F
J Gen Physiol. 2024; 156(10.
PMID: 39042091
PMC: 11270453.
DOI: 10.1085/jgp.202413563.
Tran P, Crawford T, Ragnarsson L, Deuis J, Mobli M, Sharpe S
ACS Omega. 2023; 8(29):26276-26286.
PMID: 37521635
PMC: 10373202.
DOI: 10.1021/acsomega.3c02664.
Naseem M, Gurrola-Briones G, Romero-Imbachi M, Borrego J, Carcamo-Noriega E, Beltran-Vidal J
Toxins (Basel). 2023; 15(1).
PMID: 36668861
PMC: 9866218.
DOI: 10.3390/toxins15010041.
McArthur J, Wen J, Hung A, Finol-Urdaneta R, Adams D
Elife. 2022; 11.
PMID: 35858123
PMC: 9342953.
DOI: 10.7554/eLife.74040.
Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.
Naseem M, Carcamo-Noriega E, Beltran-Vidal J, Borrego J, Szanto T, Zamudio F
J Gen Physiol. 2022; 154(8).
PMID: 35699659
PMC: 9202693.
DOI: 10.1085/jgp.202213146.
Sensory TRP Channels in Three Dimensions.
Diver M, Lin King J, Julius D, Cheng Y
Annu Rev Biochem. 2022; 91:629-649.
PMID: 35287474
PMC: 9233036.
DOI: 10.1146/annurev-biochem-032620-105738.
Peptide Toxins Targeting KV Channels.
Matsumura K, Yokogawa M, Osawa M
Handb Exp Pharmacol. 2021; 267:481-505.
PMID: 34117930
DOI: 10.1007/164_2021_500.
Molecular dysregulation of ciliary polycystin-2 channels caused by variants in the TOP domain.
Vien T, Wang J, Ng L, Cao E, DeCaen P
Proc Natl Acad Sci U S A. 2020; 117(19):10329-10338.
PMID: 32332171
PMC: 7229662.
DOI: 10.1073/pnas.1920777117.
The functionally relevant site for paxilline inhibition of BK channels.
Zhou Y, Xia X, Lingle C
Proc Natl Acad Sci U S A. 2019; 117(2):1021-1026.
PMID: 31879339
PMC: 6969516.
DOI: 10.1073/pnas.1912623117.
Development of Photocrosslinking Probes Based on Huwentoxin-IV to Map the Site of Interaction on Nav1.7.
Tzakoniati F, Xu H, Li T, Garcia N, Kugel C, Payandeh J
Cell Chem Biol. 2019; 27(3):306-313.e4.
PMID: 31732432
PMC: 7083225.
DOI: 10.1016/j.chembiol.2019.10.011.
Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways.
Dongol Y, Cardoso F, Lewis R
Toxins (Basel). 2019; 11(11).
PMID: 31671792
PMC: 6891507.
DOI: 10.3390/toxins11110626.
Cell-Free Expression of Sodium Channel Domains for Pharmacology Studies. Noncanonical Spider Toxin Binding Site in the Second Voltage-Sensing Domain of Human Na1.4 Channel.
Myshkin M, Mannikko R, Krumkacheva O, Kulbatskii D, Chugunov A, Berkut A
Front Pharmacol. 2019; 10:953.
PMID: 31555136
PMC: 6737007.
DOI: 10.3389/fphar.2019.00953.
JZTX-V Targets the Voltage Sensor in Kv4.2 to Inhibit I Potassium Channels in Cardiomyocytes.
Zhang Y, Luo J, He J, Rong M, Zeng X
Front Pharmacol. 2019; 10:357.
PMID: 31040778
PMC: 6476928.
DOI: 10.3389/fphar.2019.00357.
Unlocking the gating mechanism of Kv2.1 using guangxitoxin.
Navarro M, Milescu L, Milescu M
J Gen Physiol. 2018; 151(3):275-278.
PMID: 30563879
PMC: 6400516.
DOI: 10.1085/jgp.201812254.
The tarantula toxin GxTx detains K channel gating charges in their resting conformation.
Tilley D, Angueyra J, Eum K, Kim H, Chao L, Peng A
J Gen Physiol. 2018; 151(3):292-315.
PMID: 30397012
PMC: 6400525.
DOI: 10.1085/jgp.201812213.
Protein-Lipid Interfaces Can Drive the Functions of Membrane-Embedded Protein-Protein Complexes.
Sarkar D, Singh Y, Kalia J
ACS Chem Biol. 2018; 13(9):2689-2698.
PMID: 30080384
PMC: 6326545.
DOI: 10.1021/acschembio.8b00644.
Deglycosylation of Shaker K channels affects voltage sensing and the open-closed transition.
Lopez-Rodriguez A, Holmgren M
J Gen Physiol. 2018; 150(7):1025-1034.
PMID: 29880580
PMC: 6028503.
DOI: 10.1085/jgp.201711958.
Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.
Agwa A, Peigneur S, Chow C, Lawrence N, Craik D, Tytgat J
J Biol Chem. 2018; 293(23):9041-9052.
PMID: 29703751
PMC: 5995520.
DOI: 10.1074/jbc.RA118.002553.
APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel K10.1.
Moreels L, Peigneur S, Galan D, De Pauw E, Beress L, Waelkens E
Mar Drugs. 2017; 15(9).
PMID: 28902151
PMC: 5618426.
DOI: 10.3390/md15090287.